Mafenide Acetate, USP, For 5% Topical Solution, STERILE, Net Wt. 50 grams sterile powder per pack...
FDA Drug Recall #D-0393-2015 — Class II — February 12, 2015
Recall Summary
| Recall Number | D-0393-2015 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 12, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Par Pharmaceutical Inc. |
| Location | Spring Valley, NY |
| Product Type | Drugs |
| Quantity | 2856 cartons (each containing 5 packets) |
Product Description
Mafenide Acetate, USP, For 5% Topical Solution, STERILE, Net Wt. 50 grams sterile powder per packet, Rx only, PAR Pharmaceuticals label --- Distributed by: Par Pharmaceutical Companies, Inc. Spring Valley, NY 10977 Made in India -- NDC 49884-902-52 (packets of 50 g) and NDC 49884-902-78 (cartons of five 50 g packets)
Reason for Recall
Presence of Foreign Substance; oxidized steel, organic material and shredded polypropylene
Distribution Pattern
Nationwide
Lot / Code Information
Lots M13012 (exp. date MAR 2015), M13014 (exp. date MAR 2015), M14036 (exp. date FEB 2016), and M14077 (exp. date JUL 2016)
Other Recalls from Par Pharmaceutical Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1542-2020 | Class II | BusPIRone Hydrochloride Tablets, USP 7.5 mg ND... | Aug 10, 2020 |
| D-1071-2020 | Class II | Glycopyrrolate Tablets, USP 1 mg, 100-count bot... | Mar 30, 2020 |
| D-1035-2020 | Class III | PrediniSONE Tablets, USP 5 mg, 48-count bottle,... | Mar 4, 2020 |
| D-0843-2020 | Class III | Frovatriptan Succinate Tablets, 2.5mg, packaged... | Feb 10, 2020 |
| D-0234-2016 | Class III | Meclizine Hydrochloride Tablets USP, 25 mg Tabl... | Oct 26, 2015 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.